Allogene Therapeutics (ALLO) surges 60% premarket on ALPHA3 trial data breakthrough — April 14, 2026
Allogene Therapeutics (NASDAQ: ALLO) surged approximately 60% in premarket...
September 11, 2026
Browse Tag
premarket gainers
2 Articles
BIAF surges into Tuesday’s session as lung cancer diagnostic momentum builds
NEW YORK, March 24, 2026 — BioAffinity Technologies (NASDAQ: BIAF) is extending...
Trending News
Stay Connected
Get Every Newsletter
Get notified of the best deals on our WordPress themes.